Apogee Therapeutics
About Apogee Therapeutics
Apogee Therapeutics is a clinical stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications.
Apogee Therapeutics is listed on Rocketlist with 27 active roles. The company is categorized as Immunology & Inflammation in BioTech. Apogee Therapeutics is at Public stage, with a B2B business model, headquartered in Waltham, United States. Apogee Therapeutics was founded in 2022 and has 261 employees. Apogee Therapeutics has raised $169M. Active roles are refreshed daily from public hiring sources.